DEFINITIVE PROXY STATEMENT

Company

Jazz Pharmaceuticals plc

Filed

June 10, 2015

Period of Report

July 30, 2015

Accession Number

0001193125-15-219424

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →